CatalystX Media Book a call

AnswersEp. 09

What do MLR review and FDA rules mean for a pharma or biotech podcast?

Short answer

If a company talks about its approved or investigational product on a podcast, the episode and every clip can count as promotion. FDA rules ban promoting investigational drugs as safe or effective and expect fair balance for approved ones. CatalystX Media supports medical, legal and regulatory review with transcripts and timestamped edit logs.

Key takeaways

  • Clips and trailers are judged on their own, not as part of the full episode.
  • A benefit claim in a clip without risk information can fail fair balance.
  • Investigational products cannot be promoted as safe or effective.
  • This page is general information, not regulatory advice.

Why does a clip need its own review?

Because a viewer sees the clip without the rest of the episode. A 40-second clip that keeps a benefit claim but drops the risk discussion that followed can read as unbalanced promotion. Review each clip and trailer as a standalone piece, and use verbatim lines so nothing is reworded.

What do FDA rules say about investigational products?

US regulations say a sponsor may not represent an investigational new drug as safe or effective for the purposes it is being studied for, or otherwise promote it. Scientific exchange is allowed, but the line is easy to cross in a relaxed conversation, so brief guests before recording.

See 21 CFR 312.7 and, for prescription drug advertising, 21 CFR 202.1.

How can a podcast make MLR review faster?

Give reviewers a transcript, a timestamped edit log and the clips as separate files with their own transcripts. Flag every claim, number and product mention. When reviewers ask for a change, apply it as a marked revision so they can confirm it without watching the whole episode again.

Sources

  1. 21 CFR 312.7: Promotion of investigational drugs (eCFR)
  2. 21 CFR 202.1: Prescription-drug advertisements (eCFR)
Soumyajit Sarkar

Written by

Soumyajit Sarkar

Founder of CatalystX Media, a content production studio for podcasts in healthcare, healthtech and biotech. About the studio · LinkedIn

Published 22 November 2026 · Last updated 22 November 2026

Up next

More answers

  1. Podcast production for biotechCatalystX Media produces podcasts for biotech companies, life science investors and science communicators. We keep the science exact: trial phases, endpoints and approval status stay as the speaker said them, and terms get on-screen definitions. Your team reviews every structural cut in a timestamped log before anything is published.
    2 min
  2. How do you edit a medical podcast without changing what the guest said?Cut filler, never substance. Keep the caveat after a study result, the setup before a claim and the qualifier in “in some patients”. Use the guest's exact words in trailers and clips. CatalystX Media logs every structural cut with a timestamp, so a clinician can check the edit before it goes out.
    2 min
  3. Podcast clips for LinkedIn, Shorts and ReelsCatalystX Media turns each episode into vertical clips that make sense on their own. We pick moments from a word-level transcript, so a clip never starts mid-thought or cuts a claim in half. Every clip gets captions, a hook in the first seconds and a version for each platform.
    2 min
What do MLR review and FDA rules mean for a pharma or biotech podcast?Answers · Ep. 09
1 min1 min left
Book a call